Acumen Pharmaceuticals, Inc. (ABOS) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

Director

$70.00M (3)

—

+$70.00M

637,150

0.8810%

$1.48M

—

Robert D. Hardie

10% owner

$17.00M (2)

—

+$17.00M

7,152,312

9.89%

$16.63M

—

Sands Capital Ventures Discovery Fund III, L.P. entity

10% owner

$6.70M (1)

—

+$6.70M

3,417,075

4.73%

$7.94M

—

Paul B Manning

10% owner

$5.00M (1)

—

+$5.00M

657,985

0.9099%

$1.53M

—

John A Stalfort III

Director

$560.00K (1)

—

+$560.00K

352,219

0.4870%

$818.91K

+4,830%

Daniel Joseph OConnell

Chief Executive Officer

—

$323.85K (11)

−$323.85K

881,275

1.22%

$2.05M

+62,005%

Derek M Meisner

Chief Legal Officer & Corp Sec

—

$305.88K (19)

−$305.88K

173,999

0.2406%

$404.55K

—

Jeffrey L. Ives

Director

—

$272.33K (2) scheduled

−$272.33K

48,300

0.0668%

$112.30K

—

Matt Zuga

CFO & Chief Business Officer

—

$146.26K (11) scheduled

−$146.26K

304,924

0.4216%

$708.95K

—

Nathan B Fountain

Director

$100.00K (1)

$14.27K (1)

+$85.73K

48,150

0.0666%

$111.95K

—

Derrell Porter

Director

—

$75.24K (3) scheduled

−$75.24K

35,500

0.0491%

$82.54K

—

Eric Siemers

Chief Medical Officer

—

$63.88K (7) scheduled

−$63.88K

255,371

0.3531%

$593.74K

—

Russell Barton

Chief Operating Officer

—

$59.39K (9)

−$59.39K

205,092

0.2836%

$476.84K

—

James J. Doherty

President and CDO

—

$15.15K (2)

−$15.15K

220,900

0.3055%

$513.59K

—

Amy Schacterle

Chief Regulatory Officer

—

$2.18K (1)

−$2.18K

92,303

0.1276%

$214.60K

—

Kimberlee C Drapkin

Director

—

48,300

0.0668%

$112.30K

—

Laura Stoppel

Director

—

48,300

0.0668%

$112.30K

—

George Golumbeski

Director

—

35,500

0.0491%

$82.54K

—

Acumen Pharmaceuticals, Inc.

What the insiders did Net buying

By person